Boston Scientific is the Only Company Offering a Drug-Eluting Stent and Drug-Coated Balloon
Eluvia™ Drug-Eluting Stent and Ranger™ Drug-Coated Balloon are the only PAD devices backed by Level-1, Head-to-Head, Randomized Controlled Trials that demonstrate exceptional outcomes with differentiated technology – helping physicians make better, data-driven treatment decisions with a best-in-class drug-eluting portfolio.
Ranger™ Paclitaxel-Coated PTA Balloon Catheter
Supported by robust clinical evidence, Ranger provides exceptional outcomes, effortless deliverability, and efficient drug transfer.
Eluvia™ Drug-Eluting Vascular Stent System
Eluvia provides consistent, durable outcomes in challenging SFA disease and features a polymer design for controlled drug release.
Enhance Patient Experience
Ranger DCB and Eluvia DES were purposely designed to deliver the lowest possible drug dose through efficient drug transfer to achieve high patency with low systemic drug exposure to the patient.
Increase Operational Efficiencies
Ranger DCB is .014” guidewire compatible to help streamline atherectomy procedures. Eluvia DES has shown to reduce hospital length of stay and readmission rates.
Eluvia and Ranger are registered or unregistered trademarks of Boston Scientific Corporation or its affiliates. All other trademarks are the property of their respective owners.
Stay Up to Date
Receive emails about the latest drug-eluting technology news, innovations and events in your area.
Explore DE Resources
Get physician perspectives, clinical data sheets and other resources about drug-eluting innovations.